- Home
- MRNA vs TTMI Comparison
MRNA vs TTMI Comparison
Compare MRNA & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | TTMI |
|---|---|---|
| Founded | 2010 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 9.7B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MRNA | TTMI |
|---|---|---|
| Price | $40.11 | $92.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $31.09 | ★ $98.50 |
| AVG Volume (30 Days) | ★ 13.7M | 3.7M |
| Earning Date | 02-13-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 211.11 |
| EPS | N/A | ★ 1.68 |
| Revenue | $2,232,000,000.00 | ★ $2,906,345,000.00 |
| Revenue This Year | N/A | $13.41 |
| Revenue Next Year | $6.38 | $16.02 |
| P/E Ratio | ★ N/A | $54.70 |
| Revenue Growth | N/A | ★ 18.98 |
| 52 Week Low | $22.28 | $15.78 |
| 52 Week High | $55.20 | $111.00 |
Technical Indicators
Market Signals| Indicator | MRNA | TTMI |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 52.10 |
| Support Level | $36.66 | $81.80 |
| Resistance Level | $45.50 | $101.93 |
| Average True Range (ATR) | 3.09 | 7.67 |
| MACD | -1.07 | -1.67 |
| Stochastic Oscillator | 19.45 | 39.67 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. It organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.